In this article we will check out the progression of hedge fund sentiment towards Spirit Airlines Incorporated (NYSE:SAVE) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and […] …read more […]
In this article you are going to find out whether hedge funds think Immunomedics, Inc. (NASDAQ:IMMU) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among […] …read more […]
Yahoo Finance’s Jared Blikre joins Heidi Chung to discuss the latest oil & energy outlook as OPEC and allies agree to extend record oil production cut. …read more […]
(Bloomberg) — Tailored Brands Inc., the owner of Men’s Wearhouse and Jos. A. Bank, is considering a potential bankruptcy after the coronavirus lockdown kept America’s office workers at home, putting a damper on demand for new suits.The retailer and its advisers have started reaching out to interested parties about reworking its debts of more than $1 billion, according to people with knowledge of the matter. One option is a Chapter 11 filing, which would allow Tailored Brands to keep some of its stores operating while it seeks to shut weaker locations and satisfy its creditors, the people said.Plans are in …read more […]
Yahoo Finance’s Emily McCormick joins Heidi Chung to discuss the latest outlook for Boeing amid the coronavirus pandemic. …read more […]
The market has put on a furious rally since hitting its low on March 23, and many hesitant investors are ready to jump in.
But, as Alexander Green shares today, make sure you do these three things first for wealth preservation.
Most of my friends and neighbors know that I’m an equity analyst.
When they’re feeling particularly despondent about stocks, as they were during the coronavirus crash a few months ago, they tend to ask me some variation of the same question.
Just how low do you think the market will go?
It’s not a good question, really, because no one knows how low – …read more […]
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […] …read more […]
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds’ and successful investors’ positions as of the end of the first quarter. You can find articles about an individual hedge fund’s trades on numerous financial […] …read more […]
The National Bureau of Economic Research said Monday that the COVID-19 crisis has officially launched the U.S. economy into a recession, thus ending the longest economic expansion on record. Yahoo Finance’s Zack Guzman and Brian Cheung discuss. …read more […]
GOP officials consider voting for Joe Biden, according to The New York Times. Yahoo Finance’s Rick Newman shares the details. …read more […]
Let the predictions begin for the stock market should President Trump not win re-election. …read more […]
AstraZeneca approached drugmaker Gilead about a potential merger. Raymond James Healthcare Policy Analyst Chris Meekins joins Yahoo Finance’s On The Move to discuss. …read more […]
The National Bureau of Economic Research said Monday that the COVID-19 crisis has officially launched the U.S. economy into a recession, thus ending the longest economic expansion on record. …read more […]
Global economies have started reopening, yet the battle against COVID-19 wages on. Researchers and healthcare organizations are racing to develop a vaccine capable of preventing COVID-19 infections, and Wall Street is speculating as to who will emerge victorious.To this end, investor focus has locked in on Inovio Pharmaceuticals (INO). On June 4, Inovio, the International Vaccine Institute (IVI) and Seoul National University (SNU) Hospital announced they would collaborate on the initiation of a Phase 1/2 trial of INO’s COVID-19 DNA vaccine, INO-4800, in South Korea later this month. This will mark the country’s first COVID-19 vaccine clinical study, with it …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
